Hemolytic disease of the newborn is commonly diagnosed and managed by pediatric and newborn hospitalists. Severe cases, however, pose unique challenges for community hospitals without higher level neonatal intensive care units. This case highlights the challenges faced by pediatric hospitalists in the community and suggests a focused approach to management.
De HaasMThurikFFKoelewijnJMVan der SchootCE. Haemolytic disease of the fetus and newborn. Vox Sanguinis. 2015;109(2):99-113.
2.
DelaneyMMatthewsDC. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn. Hematology Am Soc Hematol Educ Program. 2015;2015:146-151.
3.
BhutaniVKJohnsonLH. Urgent clinical need for accurate and precise bilirubin measurements in the United States to prevent kernicterus. Clin Chem. 2004;50(3):477-480.
4.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks gestation. Pediatrics. 2004;114(1):297-316.
5.
ReeIMCSmits-WintjensVEHJvan der BomJGvan KlinkJMMOepkesDLoprioreE. Neonatal management and outcome in alloimmune hemolytic disease. Expert Rev Hematol. 2017;10(7):607-616.
6.
MaiselsMJBhutaniVKBogenDNewmanTBStarkARWatchkoJF. Hyperbilirubinemia in the newborn infant ≥ 35weeks’ gestation: an update with clarifications. Pediatrics. 2009;124(4):1193-1198.
7.
WatchkoJF. Common hematologic problems in the newborn nursery. Pediatr Clin North Am. 2015;62(2):509-524.
8.
BarringtonKJSankaranK; Canadian Paediatric Society Fetus Newborn Committee. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants. Paediatr Child Health. 2007;12(suppl_B):1B-12B.
9.
HerschelMKarrisonTWenMCaldarelliLBaronB. Evaluation of the direct antiglobulin (Coombs’) test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs’ test with ETCOc for detecting significant jaundice. J Perinatol. 2002;22(5):341-347.
10.
SegelGBLichtmanMA. Direct antiglobulin (“Coombs”) test-negative autoimmune hemolytic anemia: a review. Blood Cells Mol Dis. 2014;52(4):152-160.
11.
MurrayNARobertsIA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2007;92(2):F83-F88.
12.
MaiselsMJWatchkoJFBhutaniVKStevensonDK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks gestation. J Perinatol. 2012;32(9):660-664.
13.
LouisDMoreKOberoiSShahPS. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2014;99(4):F325-F331.
14.
ZwiersCScheffer-RathMEALoprioreEde HaasMLileyHG. Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database of Syst Rev. 2018;3(3):CD003313.
15.
LaiNMKamarAAChooYMKongJYNgimCF. Fluid supplementation for neonatal unconjugated hyperbilirubinemia. Cochrane Database of Syst Rev. 2017;8(8):CD011891.
16.
Drabik-ClaryKReddyVVBenjaminWHBoctorFN. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother. Ann Clin Lab Sci. 2006;36(2):205-207.
